This Woman is the First Ever Patient to Have Both aHUS and Cobalamin C Deficiency

When the 19-year-old French woman first visited the hospital, she was extremely lethargic. She displayed neurological symptoms. Upon kidney failure, the patient was admitted into the ICU. But soon, doctors…

Continue Reading This Woman is the First Ever Patient to Have Both aHUS and Cobalamin C Deficiency
Study: Ultomiris Resolves Complications of aHUS
Photo by Robina Weermeijer on Unsplash

Study: Ultomiris Resolves Complications of aHUS

Ultomiris, a product of Alexion Pharmaceuticals, has recently been studied in a Phase 3 clinical trial. This study was intended to ultomiris' effect on life-threatening complications of atypical hemolytic uremic…

Continue Reading Study: Ultomiris Resolves Complications of aHUS

Atypical Hemolytic Uremic Syndrome & Pregnancy: Early Diagnosis Means Better Outcomes

Atypical hemolytic uremic syndrome (aHUS) is a rare condition which can be sparked by pregnancy, although it can also occur without it. Essentially, if you are genetically predisposed to the condition,…

Continue Reading Atypical Hemolytic Uremic Syndrome & Pregnancy: Early Diagnosis Means Better Outcomes
Can This Rare Disease Drug Treat COVID-19?
jarmoluk / Pixabay

Can This Rare Disease Drug Treat COVID-19?

According to a story from Barron's, the biotechnology company Alexion Pharmaceuticals has recently announced plans to test its drug Ultomiris as a potential treatment for COVID-19. As the scientific community…

Continue Reading Can This Rare Disease Drug Treat COVID-19?

Alexion’s Ultomiris™ Met the Primary Objective in a Phase 3 Trial of Atypical Hemolytic Uremic Syndrome Patients

Alexion Pharmaceuticals, Inc., a company that is advancing a rare disease pipeline in complement biology, recently issued a series of press releases announcing positive results of a Phase 3 study…

Continue Reading Alexion’s Ultomiris™ Met the Primary Objective in a Phase 3 Trial of Atypical Hemolytic Uremic Syndrome Patients
Recently Approved Drug Ultomiris Performs Well in Atypical Hemolytic Uremic Syndrome Trial
qimono / Pixabay

Recently Approved Drug Ultomiris Performs Well in Atypical Hemolytic Uremic Syndrome Trial

According to a story from statnews.com, the biotechnology company Alexion Pharmaceuticals recently announced that its product Ultomiris, which was recently approved as a treatment for paroxysmal nocturnal hemoglobinuria, was also…

Continue Reading Recently Approved Drug Ultomiris Performs Well in Atypical Hemolytic Uremic Syndrome Trial
A Woman With Atypical Hemolytic Uremic Syndrome Was Brought Back From The Brink
paulbr75 / Pixabay

A Woman With Atypical Hemolytic Uremic Syndrome Was Brought Back From The Brink

According to a story from The Chicago Tribune, Darnesha Bankston, age 23, was rushed to the hospital just before Christmas last year with a bunch of severe, life threatening symptoms.…

Continue Reading A Woman With Atypical Hemolytic Uremic Syndrome Was Brought Back From The Brink
“All is Not Lost”: Singer-Songwriter Reflects on Her Family’s Struggle With aHUS
Pexels / Pixabay

“All is Not Lost”: Singer-Songwriter Reflects on Her Family’s Struggle With aHUS

According to a story from the Tennessean, learning that both her husband and daughter had the rare and dangerous disease atypical hemolytic uremic syndrome (aHUS) was devastating for singer-songwriter Cameron…

Continue Reading “All is Not Lost”: Singer-Songwriter Reflects on Her Family’s Struggle With aHUS
Celebrate a Holiday your Kidney will appreciate: World Kidney Month!
Source: Pixabay

Celebrate a Holiday your Kidney will appreciate: World Kidney Month!

Last week was World Kidney Day! And in fact, the whole month of March is kidney month - so there's no excuse to brush up on some key kidney facts…

Continue Reading Celebrate a Holiday your Kidney will appreciate: World Kidney Month!
How Much Would You Pay to Stay Alive? Read This Woman’s aHUS Story
https://pixabay.com/en/money-card-business-credit-card-256319/

How Much Would You Pay to Stay Alive? Read This Woman’s aHUS Story

According to CBC, Marie-Eve Chainey was on dialysis six out of seven days a week. For 15 years, this was her life. It was a necessary feat to control her…

Continue Reading How Much Would You Pay to Stay Alive? Read This Woman’s aHUS Story
Atypical Hemolytic Uremic Syndrome Patients: There’s a new Medicine Coming to the Market!
https://pixabay.com/en/medicine-pills-bottles-medical-296966/

Atypical Hemolytic Uremic Syndrome Patients: There’s a new Medicine Coming to the Market!

ChemoCentrx has been working to develop a drug to combat auto-antibody-associated vasculitis (AAV), C3 glomerulopathy (C3G), and atypical hemolytic uremic syndrome (aHUS). Its name- Avacopan. ChemoCentryx has always had a…

Continue Reading Atypical Hemolytic Uremic Syndrome Patients: There’s a new Medicine Coming to the Market!
Close Menu